Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Post-ischemic stroke rehabilitation is associated with a higher risk of fractures in older women: A population-based cohort study.

Huang HK, Lin SM, Yang CSH, Liang CC, Cheng HY.

PLoS One. 2017 Apr 17;12(4):e0175825. doi: 10.1371/journal.pone.0175825. eCollection 2017.

2.

Trends of Incidence, Mortality, and Future Projection of Spinal Fractures in Korea Using Nationwide Claims Data.

Kim TY, Jang S, Park CM, Lee A, Lee YK, Kim HY, Cho EH, Ha YC.

J Korean Med Sci. 2016 May;31(5):801-5. doi: 10.3346/jkms.2016.31.5.801. Epub 2016 Mar 25.

3.

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain.

Darbà J, Kaskens L, Sorio Vilela F, Lothgren M.

Clinicoecon Outcomes Res. 2015 Feb 9;7:105-17. doi: 10.2147/CEOR.S78349. eCollection 2015.

4.

A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality.

Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN.

Ther Clin Risk Manag. 2014 Nov 18;10:937-48. doi: 10.2147/TCRM.S72456. eCollection 2014. Review.

5.

The prevention of postmenopausal osteoporotic fractures: results of the Health Technology Assessment of a new antiosteoporotic drug.

de Waure C, Specchia ML, Cadeddu C, Capizzi S, Capri S, Di Pietro ML, Veneziano MA, Gualano MR, Kheiraoui F, La Torre G, Nicolotti N, Sferrazza A, Ricciardi W.

Biomed Res Int. 2014;2014:975927. doi: 10.1155/2014/975927. Epub 2014 Feb 4.

6.

Predictors of excess mortality after fracture: a population-based cohort study.

Melton LJ 3rd, Atkinson EJ, St Sauver JL, Achenbach SJ, Therneau TM, Rocca WA, Amin S.

J Bone Miner Res. 2014 Jul;29(7):1681-90. doi: 10.1002/jbmr.2193.

7.

Reliability and accuracy of scout CT in the detection of vertebral fractures.

Bazzocchi A, Fuzzi F, Garzillo G, Diano D, Rimondi E, Merlino B, Moio A, Albisinni U, Battista G, Guglielmi G.

Br J Radiol. 2013 Dec;86(1032):20130373. doi: 10.1259/bjr.20130373. Epub 2013 Oct 7.

8.

Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.

Migliaccio S, Resmini G, Buffa A, Fornari R, Di Pietro G, Cerocchi I, Dormi A, Gimigliano F, Mulè R, Celi M, Frigato M, Lenzi A, Tarantino U, Iolascon G, Malavolta N.

Clin Cases Miner Bone Metab. 2013 Jan;10(1):56-60. doi: 10.11138/ccmbm/2013.10.1.056.

9.

Major medical outcomes with spinal augmentation vs conservative therapy.

McCullough BJ, Comstock BA, Deyo RA, Kreuter W, Jarvik JG.

JAMA Intern Med. 2013 Sep 9;173(16):1514-21. doi: 10.1001/jamainternmed.2013.8725.

10.

Health technology assessment in osteoporosis.

Hiligsmann M, Kanis JA, Compston J, Cooper C, Flamion B, Bergmann P, Body JJ, Boonen S, Bruyere O, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY.

Calcif Tissue Int. 2013 Jul;93(1):1-14. doi: 10.1007/s00223-013-9724-8. Epub 2013 Mar 21. Review.

11.

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

Hiligsmann M, Ben Sedrine W, Bruyère O, Reginster JY.

Osteoporos Int. 2013 Aug;24(8):2291-300. doi: 10.1007/s00198-013-2272-2. Epub 2013 Feb 1.

12.

Economic burden of osteoporotic fractures in Austria.

Dimai HP, Redlich K, Peretz M, Borgström F, Siebert U, Mahlich J.

Health Econ Rev. 2012 Jun 27;2(1):12. doi: 10.1186/2191-1991-2-12.

13.

Appropriate use of anabolic treatment for severe osteoporosis.

Adami S, Brandi ML, Canonico PL, Minisola G, Minisola S, Tarantino U.

Clin Cases Miner Bone Metab. 2010 May;7(2):114-22.

14.

Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight.

Schousboe JT, Gourlay M, Fink HA, Taylor BC, Orwoll ES, Barrett-Connor E, Melton LJ 3rd, Cummings SR, Ensrud KE; Osteoporotic Fractures in Men (MrOS) and Study of Osteoporotic Fractures (SOF) Research Groups.

Osteoporos Int. 2013 Jan;24(1):163-77. doi: 10.1007/s00198-012-1936-7. Epub 2012 Feb 17.

15.

Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.

Breuil V, Cortet B, Cotté FE, Arnould B, Dias-Barbosa C, Gaudin AF, Regnault A, Roborel de Climens A, Legrand E.

Osteoporos Int. 2012 Feb;23(2):445-55. doi: 10.1007/s00198-011-1555-8. Epub 2011 Apr 6.

16.

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.

Jönsson B, Ström O, Eisman JA, Papaioannou A, Siris ES, Tosteson A, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):967-82. doi: 10.1007/s00198-010-1424-x. Epub 2010 Oct 9.

17.

Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death.

Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E.

J Am Med Dir Assoc. 2010 Oct;11(8):584-91. doi: 10.1016/j.jamda.2009.12.004. Epub 2010 Jun 30.

18.

Thoracolumbar vertebral fractures in Sweden: an analysis of 13,496 patients admitted to hospital.

Jansson KA, Blomqvist P, Svedmark P, Granath F, Buskens E, Larsson M, Adami J.

Eur J Epidemiol. 2010 Jun;25(6):431-7. doi: 10.1007/s10654-010-9461-5. Epub 2010 May 7.

19.

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study.

Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD.

CMAJ. 2009 Sep 1;181(5):265-71. doi: 10.1503/cmaj.081720. Epub 2009 Aug 4.

20.

Mortality and osteoporotic fractures: is the link causal, and is it modifiable?

Teng GG, Curtis JR, Saag KG.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S125-37. Review.

Supplemental Content

Support Center